Pharma Mar, S.A. (OTCMKTS:PHMMF – Get Free Report) hit a new 52-week high during trading on Wednesday . The stock traded as high as $81.07 and last traded at $81.07, with a volume of 0 shares traded. The stock had previously closed at $81.07.
Pharma Mar Price Performance
The company has a current ratio of 2.55, a quick ratio of 2.01 and a debt-to-equity ratio of 0.14. The business has a fifty day moving average price of $72.05 and a 200 day moving average price of $49.21.
Pharma Mar Company Profile
Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments.
Featured Articles
- Five stocks we like better than Pharma Mar
- Why Invest in 5G? How to Invest in 5G Stocks
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- 3 Tickers Leading a Meme Stock Revival
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- Transportation Stocks Investing
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Receive News & Ratings for Pharma Mar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma Mar and related companies with MarketBeat.com's FREE daily email newsletter.
